Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 19-11-2024 |
Asset Class: Equity |
Benchmark: BSE Healthcare TRI |
TER: 2.37% As on (31-05-2025) |
Status: Open Ended Schemes |
Minimum Investment: 5000.0 |
Minimum Topup: 1000.0 |
Total Assets: 108.85 Cr As on 30-05-2025(Source:AMFI) |
Turn over: - | Exit Load: For Exits within 90 days from date of allotment of units: 0.50%; For Exits beyond 90 days from date of allotment of units: NIL. |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
Standard Deviation | - |
Sharpe Ratio | - |
Alpha | - |
Beta | - |
Yield to Maturity | - |
Average Maturity | - |
Small Cap
31.94%
Others
3.91%
Large Cap
35.21%
Mid Cap
28.94%